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chlorhexidine during labour on maternal
and neonatal infections? A systematic
review of randomised trials with meta-
analysis
Charlotte Bell1* , Laura Hughes2, Trevor Akister3, Vin Ramkhelawon3, Amie Wilson4 and David Lissauer5
Abstract
Background: Infection with vaginal microorganisms during labour can lead to maternal and neonatal mortality and
morbidity.
The objective of this systematic review is to review the effectiveness of intrapartum vaginal chlorhexidine in the
reduction of maternal and neonatal colonisation and infectious morbidity.
Methods: Search strategy – Eight databases were searched for articles published in any language from inception
to October 2016.
Selection criteria – Randomised controlled trials were included.
Data Collection and analysis - Publications were assessed for inclusion. Data were extracted and assessed for risk of bias.
Relative risks from individual studies were pooled using a random effects model and the heterogeneity of treatment was
evaluated using Chi2 and I2 tests.
Results: Eleven randomised controlled trials (n = 20,101) evaluated intrapartum vaginal chlorhexidine interventions. Meta-
analysis found no significant differences between the intervention and control groups for any of the four outcomes:
maternal or neonatal colonization or infection. The preferred method for chlorhexidine administration was vaginal
irrigation.
Conclusions: Meta-analysis did not demonstrate improved maternal or neonatal outcomes with intrapartum vaginal
chlorhexidine cleansing, however this may be due to the limitations of the available studies. A larger, multicentre
randomised controlled trial, powered to accurately evaluate the effect of intrapartum vaginal chlorhexidine cleansing
on neonatal outcomes may still be informative; the technique of douching may be the most promising.
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Background
Maternal and neonatal morbidity and mortality continue
to present a serious global problem. In 2015 over 137
million live births were estimated worldwide [1], and 2.7
million neonatal deaths. [1]., A further 303,000 maternal
deaths were recorded in 2015 [2].
Between 30 and 40% of neonatal deaths worldwide are
caused by infections [3, 4] and 10.7% of maternal deaths
(37,285 annually worldwide) are due to sepsis [5]. The
greatest burden exists in low-income countries, where
99% of neonatal and maternal deaths occur [6, 7]. There-
fore, in order for interventions to have real potential for
benefit, it is imperative that they are easily accessible,
both financially and in practical application.
During the process of labour, both mother and fetus
are susceptible to infection from a range of vaginal mi-
croorganisms including Group B streptococci (GBS),
Campylobacter, Enterococcus faecalis, methicillin-resist-
ant Streptococcus aureus, Klebsiellapneumoniae, Escheri-
chia coli and Acinetobaumannii [8]. These organisms
can lead to maternal and neonatal mortality and morbid-
ities such as septicaemia, meningitis and pneumonia in
the neonate [9] and chorioamnionitis leading to severe
pelvic infection in the mother [10].
The maternal and fetal microbial profile may differ be-
tween geographical regions, with GBS having promin-
ence in high-income countries [11]. However, it has
been hypothesised that this prominence may be due to
the underestimation of GBS prevalence in low income
countries; facilities for detection are rarely available and
many births take place outside a formal healthcare set-
ting [12]. Thus far, many studies have focused separately
on GBS and other vaginal microbes [9, 13–22].
GBS in the neonate is usually acquired through verti-
cal transmission from the mother’s genital tract [23]. A
number of strategies have been suggested to reduce ver-
tical transmission of pathogens which colonise the ma-
ternal genital tract [13], including the use of intrapartum
chemoprophylaxis for GBS-colonised mothers [24] and
whole-body washing with chlorhexidine during the last
2 weeks of pregnancy [14]. In particular an important re-
search question has been the use of a chlorhexidine anti-
septic to cleanse the vagina during labour to reduce
both maternal and neonatal infection [15, 20, 25–30].
Chlorhexidine is a bisguanide antiseptic, which works by
disrupting the bacterial cell wall [31]. It is effective against
most gram-positive and some gram-negative bacteria, yeasts
and many viruses, although variably effective against envel-
oped viruses [31]. It is ineffective against bacterial spores and
mycobacteria [31]. Christensen et al. [13] found that GBS
was extremely sensitive to chlorhexidine, with a minimum
inhibitory concentration of 0.5-1 mg/l [32].Chlorhexidine
has been shown to have activity against normal vaginal bac-
teria, which cause puerperal infection, including GBS, E.coli
and enterococci [33]. Upon application it is immediately
effective, suppressing bacterial growth for up to 24 h [15].
Although not deactivated by alcohol, soaps or lavage fluid,
the presence of organic matter such as blood or amniotic
fluid may reduce the effectiveness of chlorhexidine [31].
The broad-spectrum antisepsis of the compound
makes it particularly suitable for use in the intrapartum
environment, where the colonisation of neonates and in-
fectious morbidity of mothers shows an ever-changing
pattern [34]. It is effective at a lower pH, which further
supports its use in the vagina, which typically has an en-
vironment of pH < 4.7 [35].Chlorhexidine is inexpensive,
has no effect on antimicrobial resistance, and is practical
and viable to be used in resource-limited settings [36]. It
also has a good safety profile [37] and has been studied in
the obstetric setting in concentrations ranging from 0.05–
4% [11] The compound is widely available from numerous
manufacturers worldwide. Chlorhexidine has thus been
proposed as a highly suitable compound for intra-vaginal
use to reduce maternal and neonatal sepsis [12, 38].
In 1989, the observation of a reduction of neonatal
GBS colonisation led to the recommendation for a larger
multicentre trial [16]. More recently, two Cochrane re-
views of randomised controlled trials examined aspects
of this question [17, 18] both of which were updated in
2014 [9, 19]. Lumbiganon et al. [9] reported data in their
Cochrane review which focused on trials comparing
chlorhexidine vaginal douching during labour with pla-
cebo or other vaginal disinfectant to prevent maternal
and neonatal infections, excluding GBS and HIV. The
results suggested a trend in the reduction of endometri-
tis through intrapartum vaginal chlorhexidine, but this
was not statistically significant. Ohlsson et al. [19] found
that a vaginal intrapartum chlorhexidine intervention
reduced the GBS colonisation of neonates, but did not
reduce early-onset disease, including GBS infection, GBS
pneumonia or GBS meningitis. The authors of both re-
views concluded that a randomised controlled trial with
adequate power and standardised intervention was required,
but Ohlsson et al. [19] commented that in developed
countries, this may be difficult to justify in the era of anti-
biotic prophylaxis for GBS infection. However, the scope of
these reviews was narrower than this review, and excluded
a number studies as they combined the interventions of
vaginal cleansing and infant washing. Furthermore the
Cochrane reviews separated neonatal infections based on
the microorganism responsible, making an overall assess-
ment of the efficacy of this intervention difficult.
The following systematic review and meta-analysis of
randomised controlled trials focuses on the intrapartum
vaginal interventions in vaginal deliveries only, measur-
ing both maternal and neonatal outcomes in terms of
infectious morbidity and mortality, irrespective of infec-
tious organisms.
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Methods
Types of studies included randomised controlled trials
only, comparing the use of intrapartum vaginal chlor-
hexidine cleansing to no chlorhexidine use or placebo or
other vaginal disinfectant, for the reduction of maternal
or neonatal infection. Studies that considered HIV-
positive participants exclusively were excluded.
Participants considered for inclusion in this review are
women undergoing vaginal delivery, in the intrapartum
period and having vaginal chlorhexidine cleansing in
any setting.
Types of interventions considered were vaginal disin-
fection with chlorhexidine by any method during labour,
compared with placebo or no vaginal disinfection.
Maternal outcomes measured were 1) Colonization
during the post-partum period and 2) Clinical infection
and / or sepsis during the post-partum period. Neonatal
outcomes measured were 1) Colonization during the
neonatal period and 2) Clinical infection and / or sepsis
during the neonatal period.
Eight electronic databases were searched (PubMed,
Medline, Embase, Cochrane Central Register of Con-
trolled Trials, CINAHL, AIM, the Reproductive Health
Library, and BioMed Central: from database inception to
10/2016. The following search terms were used ‘Chlor-
hexidine’, ‘vaginal antiseptic’, ‘vaginal wipe’, ‘vaginal douche’,
‘vaginal cleansing’, ‘bathing’ with ‘pregnancy’, ‘postpartum’,
‘labour’ ‘intrapartum’, ‘neonatal’, ‘peripartum’ and ‘meningi-
tis’, ‘pneumonia’ ‘group B strep’, ‘infection’, ‘HIV’, ‘sepsis’,
‘mortality’, ‘omphalitis’, ‘Klebsiella’, ‘chorioamnionitis’, ‘endo-
metritis’, ‘maternal’, ‘infant’, ‘postnatal’. No language restric-
tions were applied. Databases were searched for papers
published until October 2016.
All randomised trials examining the use of vaginal chlor-
hexidine washing during labour, by any method, which
reported maternal or neonatal outcomes were included.
Three authors completed the searches independently
(C Bell, L Hughes, T Akister). Two authors independ-
ently (C Bell, L Hughes) screened the titles and abstracts
to assess for inclusion or exclusion. The two authors
then read each paper identified as a result of the search
strategy and made a decision on whether it should be in-
cluded or excluded on the basis of all the defined inclu-
sion criteria. Disagreements were resolved by discussion
(T Akister, D Lissauer).
Data was extracted by two authors independently
(T Akister, V Ramkhelawon) and tabulated using
Miscrosoft Excel. Any disagreements were resolved by
discussion amongst the authorship group and consen-
sus. Data was entered into Review Manager Software
Revman 5.0 and checked for accuracy.
Two review authors (T Akister, V Ramkhelawon) inde-
pendently assessed risk of bias for each study using the
criteria outlined in the Cochrane Handbook for Systematic
Reviews of Interventions [39]. Any disagreement was re-
solved by discussion or by involving a third review author.
Specifically, the following aspects of risk bias were
assessed in detail: 1) Sequence generation (checking for
possible selection bias), 2) Allocation concealment (check-
ing for possible selection bias), 3) Blinding (checking for
possible performance bias), 4) Incomplete outcome data
(checking for possible attrition bias through withdrawals,
dropouts, protocol deviations), 5) Selective reporting bias,
6) Other sources of bias.
The overall risk of bias was made using judgements
about whether studies were at high risk of bias, accord-
ing to the criteria given in the Cochrane Handbook for
Systematic Reviews of Interventions [39]. The likely mag-
nitude and direction of the biases described in points 1
to 6 above was assessed and whether it was likely to im-
pact on the findings.
Data for effect estimates, including 95% confidence in-
tervals, were directly extracted. These results were then
included in the meta-analysis, using a random effects
model to pool the relative risks from individual studies.
The heterogeneity of treatment was evaluated using Chi2
and I2 tests and presented as forest plots. Analyses were
undertaken using Revman 5.0 statistical software and
Mantel-Haenszel analysis.
Results
We identified 68 unique papers after searching PubMed,
Embase, Medline, The Cochrane Library and Biomed Cen-
tral. No papers were identified after searching the CINAHL,
AIM or RHL databases. Eleven RCTs involving 20,101
women and their infants, were suitable to be included in a
systematic review and meta-analysis (Fig. 1). Characteristics
of included studies are detailed in Table 1, including poten-
tial confounding factors. Only two of the studies [27, 40]
were undertaken in low resource settings (Table 1).
There was no significant difference in maternal
colonization when using vaginal chlorhexidine intrapar-
tum when compared to the control (Fig. 2). Two studies
[21, 27] investigated the effect of chlorhexidine on mater-
nal colonization, including 53 participants in the interven-
tion group and 51 in the control group, which also
showed no significant difference on colonization (Relative
risk (RR) 0.61, 95% confidence intervals (CI) 0.05-8.08)
Heterogeneity – I2 = 93%, P < 0.001.
Five studies [28, 30, 40–42] (Fig. 2) containing a total of
12,154 participants (6067 intervention and 6087 control)
did not show a statistically significant effect in maternal
morbidity (RR 0.91 95% CI 0.69-1.20) with the chlorhexi-
dine intervention. Heterogeneity – I2 = 52%, P = 0.08.
The incidence of neonatal colonization was not reduced
with any chlorhexidine intervention (Fig. 2). Three studies
[22, 42, 43] reported on neonatal colonization on a total
of 1948 neonates (949 intervention 999 control) and also
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showed no reduction in bacterial transmission (RR 0.75 CI
0.46-1.22). Heterogeneity – I2 = 90%, P < 0.001.
Five studies [20, 29, 30, 41, 42] (Fig. 2) looked at
neonatal infection and sepsis. This included 4297 infants
in the intervention arm and 4342 in the control group.
There was also no reduction with vaginal chlorhexidine
(RR 0.74 CI 0.52-1.06). There was significant hetero-
geneity in the meta-analysis of neonatal colonization
(p < 0.001, I2 = 90%), but no evidence of significant
heterogeneity in the meta-analysis of neonatal sepsis/
infection as their outcome (p < 0.26, I2 = 24%). Further
analysis of this outcome was undertaken, discriminating
between douching and wipes/gel/cream (Fig. 2). The
results favoured the douching method, for which the
result for neonatal colonization was significant (p < 0.001)
(Fig. 2). Unfortunately, this particular analysis only
contained one study [42].
Discussion
The meta-analysis did not demonstrate a reduction in
maternal colonization or in maternal sepsis/infection
when using intrapartum vaginal chlorhexidine cleansing.
The incidences of neonatal colonization and neonatal
infection/sepsis were also not significantly reduced by
this intervention. However, although these results did
not show a statistically significant reduction in out-
comes, there appeared to be a trend towards a reduction
in maternal infection and neonatal colonisation and in-
fection with the douching method, which suggest this
subject may warrant further study.
All of the 11 studies reviewed were randomised trials,
but seven were assessed to be at high risk of bias in one or
more categories. For example, two studies [23, 27] did not
perform an intention to treat analysis, which can lead to a
failure to preserve randomisation of the groups.
There is significant clinical heterogeneity in the studies
analysed (Table 1). In particular, different methods of vagi-
nal cleansing with chlorhexidine were used. In eight studies
[20, 21, 27, 30, 41, 42, 44] an irrigation or ‘douching’
method was used, whilst others used gel [23], wipes [40] or
cream [22] . In the analysis of these treatment differences,
douching was suggested to be more effective, but this may
not be a reliable conclusion as only one study [42] with
neonatal colonization as an outcome employed irrigation
and only one study with maternal sepsis/infection as an
outcome [40] used wipes. It is however conceivable that the
act of mechanically flushing the vaginal walls could play a
part in the physical removal of pathogenic and commensal
Fig. 1 PRISMA flow diagram of search strategy and process of selecting articles
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bacteria. This would oppose the theory that a prolonged
contact time found with the use of gel or cream would
enhance the bactericidal effects of chlorhexidine.
The use of a control also varied between studies, with
three [20, 41, 42] using sterile saline, three [28, 30, 44]
using sterile water, one [23] using another placebo and
four [21, 22, 27, 40] using no intervention as controls.
Aside from the lack of blinding in the non-treatment
controls, confounding may have occurred in the use of
saline or water. The effect of these controls on vaginal
bacteria, whether chemical or mechanical, should be
determined.
Some studies included in their analysis the outcomes of
mothers who underwent emergency caesarean section [20,
23, 30, 41]. Studies that exclusively focused on women
undergoing caesarean section were excluded from our re-
view, but a proportion of women in labour will inevitably
require surgical intervention. The intention-to-treat ana-
lysis employed may have preserved randomisation, but
may also have had an impact on the outcome, as the con-
tamination of the neonate with vaginal bacteria may be
less likely if that neonate has not passed through the va-
gina. Notably, the studies by Rouse et al. [30, 41] also ad-
ministered one dose of a second-generation cephalosporin
to these mothers, which also risks masking the effects of
vaginal washing on maternal infection. The same studies
also gave prophylactic antibiotics to any mother at risk of
early onset GBS infections, which may also have masked
both maternal and neonatal complications. In contrast,
Burman et al. [20] had ‘GBS carrier status’ as an inclusion
criterion (Table 1). In addition, some of the studies did
not take account of the duration of labour or prolonged
rupture of membranes, which may have led to bias, whilst
the Rouse studies [30, 41] administered prophylactic anti-
biotics to these participants (Table 1).
The studies reviewed also differ in terms of the level of
care provider carrying out the intervention, with four
[20, 21, 40, 42] using midwives and five [23, 28, 30, 41, 44]
using doctors and/or medical students, two unknown
[22, 27]. However, the person(s) within each study re-
sponsible for performing the intervention (or control,
where applicable) varied within the study itself, which
may also have influenced outcomes.
The studies reviewed showed heterogeneity for their
location. Nine studies were conducted in high-income
countries (4 USA, 5 Scandinavia) and only two in
developing countries (1 South Africa, 1 Zimbabwe). The
Zimbabwean study [27] showed a highly statistically sig-
nificant result favouring the use of chlorhexidine for the
prevention of maternal colonisation. The South African
study failed to show a favourable result for the outcome
of maternal infection/sepsis. Notably, this study also
used vaginal wiping instead of irrigation as the method
of intervention, which may be a less effective technique.
However, despite such notable heterogeneity between
studies, the authors feel that the studies showed suffi-
cient homogeneity in their populations, interventions
and outcomes to warrant meta-analysis. It was also felt
that the efficacy of the intervention, that is vaginal, intra-
partum chlorhexidine, should not be directly affected by
the geographical location of the study. Nonetheless, the
intervention itself may be economically and technically
viable for a low-income setting.
Cochrane reviews [9, 17–19] have previously focused
on GBS and other infections separately, concluding that
intravaginal/intrapartum chlorhexidine was effective in
significantly reducing neonatal colonization with GBS.
But they stated that this alone was not sufficient to
support the use of the intervention. Our review has also
found that, when assessing maternal and neonatal
colonization and infectious morbidity of all organisms
(excluding HIV) there is no statistical significance to the
results, but there is a suggestion that intervention may
lead to a reduction in neonatal infection/sepsis.
Goldenberg et al. [38] analysed studies using vaginal
chlorhexidine, with or without a neonatal wash, with
particular reference to the low income countries. Their
analysis of two large, non-randomised studies suggested
that one or both of these interventions was successful in
improving both maternal and neonatal outcomes. How-
ever we believe that it is still useful to separate the two
interventions as in our review, to determine the individ-
ual effect of each. This is particularly important when
considering potential implementation in the low-income
countries, where cost-effectiveness and cost-benefit ana-
lyses would be of paramount importance, as well as the
simplicity of the intervention.
McClure et al. [11] reviewed studies using any chlor-
hexidine interventions including vaginal, neonatal wipes
and umbilical cord cleansing. The group suggested that
although several studies reviewed showed promising re-
sults, the lack of truly randomized trial evidence stood as
a major barrier to implementing the use of chlorhexidine
interventions in low-resource settings. Again, we feel that
it is advantageous to separate the interventions in order to
assess their individual efficacy as exclusive interventions,
before combining the outcomes in such a review. Mullany
et al. [12] used similar inclusion criteria to McClure et al.
[11] for their review, which concluded that although the
various chlorhexidine interventions showed promise in re-
ducing neonatal morbidity and mortality, their individual
efficacy should be determined before implementation in
low-resource settings. We have begun this process in our
review, in order to ascertain whether a larger scale rando-
mised controlled trial would be justifiable for the separate
intervention of vaginal chlorhexidine washing.
The two Cochrane reviews did this in relation to vagi-
nal, intrapartum chlorhexidine, but may have limited
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Fig. 2 Forest plot comparing the following outcomes and interventions: 1) maternal colonisation; 2) maternal sepsis/infection; 3) neonatal colonisation; 4)
neonatal sepsis/infection; 5) maternal sepsis/infection – douching; 6) maternal sepsis/infection – wipes; 7) neonatal colonisation – douching; 8) neonatal
colonisation – gel/cream
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interpretation by separating the causative organisms. As it
has been hypothesized that the apparent low prevalence of
GBS in low-resource settings may be attributable to
under-diagnosis [12], we felt that it was important to con-
duct our review to include all causative agents.
The Dykes [21], Adriaanse [23], Burman [20] and
Stray-Pedersen [42] studies all supported the use of vagi-
nal intrapartum chlorhexidine. All of these studies were
conducted in Scandinavian hospitals; therefore the re-
sults may not be generalisable to the populations of less
developed countries, where a majority of the maternal
and neonatal burden of disease exists. Furthermore it is
in this setting that the lack of resources and high num-
ber of community births make an effective, safe, cheap
and low-skill intervention particularly beneficial. In this
setting non-randomised studies such as Mushangwe [45]
and Taha [46] show promising results.
Conclusions
Our review shows that intrapartum, vaginal chlorhexidine
may lead to a reduction in neonatal infection/sepsis. It is
still unclear whether chlorhexidine concentration and
method of administration will have a significant impact on
outcome, due to the heterogeneity of existing studies. It is
therefore our belief that a larger, multicentre, randomised
controlled clinical trial in a low-resource setting is justified
based on our analysis. Such a trial would require rigor-
ously defined inclusion criteria such as in the Rouse et al.
studies [30, 41]. These patients were nulliparous, more
than 32 weeks gestation and exclusion criteria were:
contraindication to digital cervical examination, active
genital herpes, chorioamnionitis prior to randomisation
and allergy to chlorhexidine. The studies also carried out
double-blinding and computer randomisation.
The use of intrapartum vaginal chlorhexidine should
also be considered separately to neonatal skin cleansing,
to provide more specific information regarding the effi-
cacy of such interventions. As there are still unanswered
question regarding the optimum concentration of chlor-
hexidine, the frequency and timing (pre/post rupture of
membranes) of the intervention and the method used
(wipes/gel/cream versus douching), further studies may
need to also address these issues.
Abbreviation
GBS: Group B streptococci
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